American International Group’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-20,244
| Closed | -$375K | – | 3059 |
|
|
2023
Q3 | $375K | Buy |
20,244
+8,433
| +71% | +$95.4K | ﹤0.01% | 1771 |
|
|
2023
Q2 | $131K | Buy |
11,811
+8
| +0.1% | +$111 | ﹤0.01% | 2416 |
|
|
2023
Q1 | $159K | Buy |
11,803
+235
| +2% | +$4.07K | ﹤0.01% | 2246 |
|
|
2022
Q4 | $143K | Sell |
11,568
-42
| -0.4% | -$595 | ﹤0.01% | 2342 |
|
|
2022
Q3 | $162K | Buy |
11,610
+164
| +1% | +$2.64K | ﹤0.01% | 2279 |
|
|
2022
Q2 | $158K | Sell |
11,446
-953
| -8% | -$15.3K | ﹤0.01% | 2339 |
|
|
2022
Q1 | $202K | Sell |
12,399
-872
| -7% | -$13.7K | ﹤0.01% | 2230 |
|
|
2021
Q4 | $216K | Sell |
13,271
-2,070
| -13% | -$34.9K | ﹤0.01% | 2322 |
|
|
2021
Q3 | $228K | Sell |
15,341
-365
| -2% | -$5.84K | ﹤0.01% | 2358 |
|
|
2021
Q2 | $314 | Buy |
15,706
+595
| +4% | +$11.8K | ﹤0.01% | 2227 |
|
|
2021
Q1 | $349 | Buy |
15,111
+40
| +0.3% | +$1.11K | ﹤0.01% | 2036 |
|
|
2020
Q4 | $372 | Sell |
15,071
-434
| -3% | -$14.4K | ﹤0.01% | 1919 |
|
|
2020
Q3 | $643K | Sell |
15,505
-352
| -2% | -$16.2K | ﹤0.01% | 1467 |
|
|
2020
Q2 | $760K | Buy |
15,857
+963
| +6% | +$74.4K | ﹤0.01% | 1369 |
|
|
2020
Q1 | $938K | Sell |
14,894
-861
| -5% | -$77.4K | 0.01% | 1138 |
|
|
2019
Q4 | $1.95M | Sell |
15,755
-133
| -0.8% | -$11.9K | 0.01% | 1008 |
|
|
2019
Q3 | $1.05M | Buy |
15,888
+144
| +0.9% | +$9.67K | ﹤0.01% | 1268 |
|
|
2019
Q2 | $1.25M | Buy |
15,744
+1,776
| +13% | +$159K | ﹤0.01% | 1199 |
|
|
2019
Q1 | $1.56M | Sell |
13,968
-453
| -3% | -$49.5K | 0.01% | 1100 |
|
|
2018
Q4 | $1.45M | Sell |
14,421
-111
| -0.8% | -$11.5K | 0.01% | 1081 |
|
|
2018
Q3 | $1.84M | Buy |
14,532
+263
| +2% | +$27.8K | 0.01% | 1088 |
|
|
2018
Q2 | $1.2M | Buy |
14,269
+13,860
| +3,389% | +$1.01M | ﹤0.01% | 1271 |
|
|
2018
Q1 | $25K | Sell |
409
-15
| -4% | -$904 | ﹤0.01% | 2986 |
|
|
2017
Q4 | $25K | Buy |
+424
| New | +$26.7K | ﹤0.01% | 3004 |
|
|
2017
Q3 | – | Sell |
-434
| Closed | -$53K | – | 3008 |
|
|
2017
Q2 | $53K | Buy |
434
+61
| +16% | +$7.07K | ﹤0.01% | 2985 |
|
|
2017
Q1 | $42K | Sell |
373
-14
| -4% | -$1.63K | ﹤0.01% | 2872 |
|
|
2016
Q4 | $42K | Hold |
387
| – | – | ﹤0.01% | 2895 |
|
|
2016
Q3 | $63.7K | Sell |
387
-17
| -4% | -$2.68K | ﹤0.01% | 2828 |
|
|
2016
Q2 | $57.6K | Sell |
404
-47
| -10% | -$6.85K | ﹤0.01% | 2911 |
|
|
2016
Q1 | $58K | Sell |
451
-9
| -2% | -$1.06K | ﹤0.01% | 3796 |
|
|
2015
Q4 | $69K | Buy |
460
+76
| +20% | +$12.9K | ﹤0.01% | 3733 |
|
|
2015
Q3 | $64K | Buy |
384
+35
| +10% | +$7.7K | ﹤0.01% | 3798 |
|
|
2015
Q2 | $84.2K | Buy |
349
+59
| +20% | +$15.7K | ﹤0.01% | 3787 |
|
|
2015
Q1 | $81.8K | Buy |
290
+29
| +11% | +$6.28K | ﹤0.01% | 3716 |
|
|
2014
Q4 | $40.7K | Buy |
261
+17
| +7% | +$3.14K | ﹤0.01% | 4052 |
|
|
2014
Q3 | $57.8K | Buy |
244
+10
| +4% | +$2.55K | ﹤0.01% | 3914 |
|
|
2014
Q2 | $55.4K | Sell |
234
-4,654
| -95% | -$1.23M | ﹤0.01% | 3927 |
|
|
2014
Q1 | $1.61M | Buy |
4,888
+132
| +3% | +$44.5K | 0.01% | 1227 |
|
|
2013
Q4 | $325K | Buy |
4,756
+547
| +13% | +$31.6K | ﹤0.01% | 2355 |
|
|
2013
Q3 | $291K | Buy |
4,209
+962
| +30% | +$47.5K | ﹤0.01% | 2388 |
|
|
2013
Q2 | $146K | Buy |
+3,247
| New | +$111K | ﹤0.01% | 2830 |
|
American International Group's ICPT Position: Q4 2023 in Review
American International Group sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 20,244 shares — an estimated $375K sold.
American International Group first reported a position in ICPT in Q2 2013 and held it in 41 quarters. The position peaked at $1.95M in Q4 2019. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.
- American International Group reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
- American International Group sold 20,244 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $375K.
- American International Group first reported a position in Intercept Pharmaceuticals, Inc. in Q2 2013 and held it in 41 quarters.
- American International Group's Intercept Pharmaceuticals, Inc. position peaked at $1.95M in Q4 2019.
- 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.
Based on American International Group's 13F filing for Q4 2023, filed 13 Feb 2024.